(Q48516355)

12 February 2018

title

Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease. (English)

1 reference

12 February 2018

0 references

0 references

0 references

P Falkai

10

0 references

author name string

H Kessler

1

1 reference

12 February 2018

F-G Pajonk

2

1 reference

12 February 2018

P Meisser

3

1 reference

12 February 2018

T Schneider-Axmann

4

1 reference

12 February 2018

K-H Hoffmann

5

1 reference

12 February 2018

T Supprian

6

1 reference

12 February 2018

W Herrmann

7

1 reference

12 February 2018

R Obeid

8

1 reference

12 February 2018

G Multhaup

9

1 reference

12 February 2018

T A Bayer

11

1 reference

12 February 2018

publication date

1 June 2006

1 reference

12 February 2018

Journal of Neural Transmission

published in

1 reference

12 February 2018

volume

113

1 reference

12 February 2018

issue

11

1 reference

12 February 2018

page(s)

1763-1769

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1007/s00702-006-0485-7

exact match

0 references

cites work

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0485-7

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0485-7

Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0485-7

Elevation of serum copper levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-006-0485-7

Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome

21 January 2018

1 reference

12 December 2020

Reference values of neuroactive amino acids in the cerebrospinal fluid by high-performance liquid chromatography with electrochemical and fluorescence detection

1 reference

12 December 2020

The neuronal adaptor protein X11alpha interacts with the copper chaperone for SOD1 and regulates SOD1 activity

1 reference

12 December 2020

Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.

1 reference

12 December 2020

Long-term high copper intake: effects on indexes of copper status, antioxidant status, and immune function in young men.

1 reference

12 December 2020

Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease

1 reference

12 December 2020

Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.

1 reference

12 December 2020

Copper, iron and zinc in Alzheimer's disease senile plaques.

1 reference

12 December 2020

Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method

1 reference

12 December 2020

The metallobiology of Alzheimer's disease

1 reference

12 December 2020

Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease.

1 reference

12 December 2020

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

1 reference

12 December 2020

Lipid peroxidation and free radical scavengers in Alzheimer's disease

1 reference

12 December 2020

Mechanisms of biosynthesis of mammalian copper/zinc superoxide dismutase

1 reference

12 December 2020

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

1 reference

12 December 2020

The beta A4 amyloid precursor protein binding to copper.

1 reference

12 December 2020

Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease.

1 reference

12 December 2020

The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)

1 reference

12 December 2020

Neuropeptides and Alzheimer's disease

1 reference

12 December 2020

BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper.

1 reference

12 December 2020

CSF neurotransmitter markers in Alzheimer's disease

1 reference

12 December 2020

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

1 reference

12 December 2020

In vivo reduction of amyloid-beta by a mutant copper transporter

1 reference

12 December 2020

It all sticks together--the APP-related family of proteins and Alzheimer's disease

1 reference

12 December 2020

CSF markers for Alzheimer's disease: Total tau, phospho-tau and Aβ42

1 reference

12 December 2020

Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron.

1 reference

12 December 2020

Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion

1 reference

12 December 2020

Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders

1 reference

12 December 2020

Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice

1 reference

12 December 2020

Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis

1 reference

12 December 2020

Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.

1 reference

12 December 2020

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress.

1 reference

12 December 2020

Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease . a case-control study

1 reference

12 December 2020

Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice

1 reference

12 December 2020

10.1007/S00702-006-0485-7

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018